BackBellevue Life Sciences Acquisition Overview

Bellevue Life Sciences Acquisition Other Current Assets

Bellevue Life Sciences Acquisition's other current assets is $770K.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$771646.00
29.33% YoYΔ $-320298.00 vs prior year quarter

Peer average / median

Loading

Bellevue Life Sciences Acquisition Other Current Assets History

Loading

Bellevue Life Sciences Acquisition vs. peers: Other Current Assets Comparison

Loading

Bellevue Life Sciences Acquisition Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bellevue Life Sciences Acquisition (BLAC) FAQ

As of the most recent data (June 2026), BLAC shows a other current assets of $770K. That compares with $1.1M in the prior-year period — down 29.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLAC's other current assets is now $770K (was $1.1M) — a 29.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bellevue Life Sciences Acquisition is outperforming or lagging.

Tracking BLAC's other current assets over time shows whether Bellevue Life Sciences Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $770K That compares with $1.1M in the prior-year period — down 29.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Bellevue Life Sciences Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $770K) with ownership activity and broader fundamentals.